# Delineating Swallowing Impairment and Decline in ALS

> **NCT02962050** · — · COMPLETED · sponsor: **University of Florida** · enrollment: 109 (actual)

## Conditions studied

- Amyotrophic Lateral Sclerosis

## Interventions

- **PROCEDURE:** Videofluoroscopic Swallowing Study (VFSS)
- **DEVICE:** Voluntary Peak Cough Flow Testing
- **DEVICE:** Iowa Oral Performance Instrument
- **DRUG:** Capsaicin Challenge
- **DEVICE:** Pulmonary Function Testing
- **OTHER:** Eating Assessment Tool 10
- **OTHER:** The Center for Neurologic Study Bulbar Function Scale

## Key facts

- **NCT ID:** NCT02962050
- **Lead sponsor:** University of Florida
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-31
- **Primary completion:** 2023-02-16
- **Final completion:** 2023-02-16
- **Target enrollment:** 109 (ACTUAL)
- **Last updated:** 2023-02-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02962050

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02962050, "Delineating Swallowing Impairment and Decline in ALS". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02962050. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*